The decrease in Rhythm Pharmaceuticals' stock price is a direct reaction to the Q1 earnings report. Typically, earnings reports can significantly impact a company's stock price in the short term, depending on whether the reported financial performance meets, exceeds, or falls short of market expectations. In this case, the market's reaction suggests that the earnings report may have not met investor expectations, leading to a decrease in stock price.